Ubiquitination in cancer: mechanisms, signaling networks and potential therapeutic opportunities
Molecular Cancer · Published 2026-08-05 · DOI 10.1186/s12943-026-02768-6
Free full text
Authors (3)
Yan Xue, Huiying Wu, Wu Liu
Abstract
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Publication details
- Year
- 2026
Citation
Xue, Y., Wu, H., Liu, W. (2026). Ubiquitination in cancer: mechanisms, signaling networks and potential therapeutic opportunities. Molecular Cancer. https://doi.org/10.1186/s12943-026-02768-6
Related articles
- AcTor, a novel mTOR stimulator, potentiates ixazomib for the treatment of acute myeloid leukemia · Molecular Cancer · 2026 · Same journal
- Breaking the immune “cold niche” in bone metastasis: core mechanisms of the multidimensional interwoven regulatory network and precision breakthrough strategies · Molecular Cancer · 2026 · Same journal
- Redifferentiation-enabled TSHRCART cells overcome antigen loss in aggressive thyroid cancers · Molecular Cancer · 2026 · Same journal
- Landscape of T-cell bispecific antibodies in cancer therapy: therapeutic strategies, challenges and future prospection · Molecular Cancer · 2026 · Same journal
- Trace elements and tumors: homeostatic networks, molecular mechanisms and new horizons for precision intervention · Molecular Cancer · 2026 · Same journal
- Autophagy in cancer — functional plasticity, therapeutic paradox, and the road to precision modulation: a comprehensive review · Molecular Cancer · 2026 · Same journal
- Multimodal sequencing identifies synergistic mechanisms driving resistance to neoadjuvant nivolumab treatment in hepatocellular carcinoma · Molecular Cancer · 2026 · Same journal
- Reprogramming the pancreatic ductal adenocarcinoma microenvironment: a novel integrin-targeted cytotoxin, ProAgio, potentiates chemotherapy · Molecular Cancer · 2026 · Same journal
- ADSL drives fumarate mediated scrib-rictor complex formation to promote metastasis dissemination in triple-negative breast cancer · Molecular Cancer · 2026 · Same journal
- Liposomal drug delivery for lung cancer therapy: progress, challenges, and future perspectives · Molecular Cancer · 2026 · Same journal